1. Home
  2. ICUI vs CBT Comparison

ICUI vs CBT Comparison

Compare ICUI & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$142.61

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo Cabot Corporation

CBT

Cabot Corporation

HOLD

Current Price

$66.16

Market Cap

4.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICUI
CBT
Founded
1984
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.0B
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
ICUI
CBT
Price
$142.61
$66.16
Analyst Decision
Buy
Hold
Analyst Count
5
3
Target Price
$179.50
$66.33
AVG Volume (30 Days)
213.6K
553.4K
Earning Date
11-06-2025
02-02-2026
Dividend Yield
N/A
2.71%
EPS Growth
N/A
N/A
EPS
N/A
6.02
Revenue
$2,320,363,000.00
$3,713,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.84
P/E Ratio
N/A
$11.03
Revenue Growth
N/A
N/A
52 Week Low
$107.00
$58.33
52 Week High
$175.51
$92.89

Technical Indicators

Market Signals
Indicator
ICUI
CBT
Relative Strength Index (RSI) 47.09 51.50
Support Level $146.11 $65.61
Resistance Level $149.00 $66.65
Average True Range (ATR) 3.45 1.33
MACD -0.95 -0.09
Stochastic Oscillator 31.01 33.21

Price Performance

Historical Comparison
ICUI
CBT

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

Share on Social Networks: